| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000256006.1 |
Bosutinib |
Chronic Lymphocytic Leukemia |
0.044964628 |
Resistant |
| ENSG00000256006.1 |
Bosutinib |
Bladder urothelial carcinoma |
0.043558917 |
Sensitive |
| ENSG00000256006.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047834074 |
Sensitive |
| ENSG00000256006.1 |
Bosutinib |
Sarcoma |
0.026276675 |
Sensitive |
